Suspected medullary carcinoma |
• IHC panel (calcitonin, thyroglobulin, CEA, chromogranin) |
• Serum calcitonin |
Suspected anaplastic carcinoma |
• IHC for pan-cytokeratin |
Suspected metastatic carcinoma |
• IHC for TTF-1 (If TTF-1 negative, then expand IHC panel based on cytomorphology and clinical setting to identify primary) |
Suspected lymphoma |
• Flow cytometric immunophenotyping |
Suspected parathyroid lesion |
• IHC for TTF-1, PTH, chromogranin |
• May consider PTH level assessment on FNA sample |
Suspected metastatic thyroid carcinoma to lymph node |
• IHC for TTF-1, thyroglobulin, calcitonin |
• May consider thyroglobulin level assessment on FNA sample |
Atypical/Borderline/Suspicious FNA |
• No specific tests based on insufficient evidence |